Preventive effects with teriparatide or alendronate on the progression of vertebral collapse
Phase of Trial: Phase IV
Latest Information Update: 22 Sep 2019
Price : $35 *
At a glance
- Drugs Teriparatide (Primary) ; Alendronic acid
- Indications Osteoporosis; Vertebral fracture
- Focus Therapeutic Use
- Acronyms T-WRAP
- 01 Dec 2016 Status changed from recruiting to completed.
- 31 Aug 2015 Planned End Date changed from 30 Sep 2015 to 30 Oct 2015 as reported by University Hospital Medical Information Network - Japan record.
- 29 Jul 2014 Status changed from not yet recruiting to recruiting, as per University Hospital Medical Information Network - Japan record.